About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Trials in Miami | 8,701 Studies Near You | Clareo Health

Clinical Trials LocationsMiami

Clinical Trials in Miami

Discover 8,701 clinical trials near Miami, Florida. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Filters

Sort by

Status

Recruiting(Enrolling)

Not yet recruiting

Active, not recruiting

Enrolling by invitation(Enrolling)

Completed

Terminated

Phase

Early Phase 1

Phase 1

Phase 1/Phase 2

Phase 2

Phase 2/Phase 3

Phase 3

Phase 4

Not Applicable

Eligibility

Accepts healthy volunteers

Showing 8541-8560 of 8,701 trials

COMPLETEDNA< 1 mile

The Use of Anabolic Steroids to Improve Function After Spinal Cord Injury

NCT00223769

The purpose of this study is to determine the effect of oxandrolone on the function and quality of life of patients with chronic spinal cord injury.

Spinal Cord Injury

US Department of Veterans Affairs40 participantsStarted Jan 2004

Miami, Florida, United States

COMPLETEDPhase 3< 1 mile

A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of Psoriasis

NCT00293917

A study to assess the long-term safety of tacrolimus cream in the treatment of psoriasis

Astellas Pharma Inc658 participantsStarted Jan 2006

Birmingham, Alabama, United States • Fresno, California, United States • Santa Monica, California, United States +34 more locations

Find Trials by Condition in Miami

Breast Cancerin Miami Lung Cancerin Miami Prostate Cancerin Miami Colorectal Cancerin Miami Melanomain Miami Leukemiain Miami Lymphomain Miami Pancreatic Cancerin Miami Ovarian Cancerin Miami Brain Cancerin Miami Diabetesin Miami

Data from ClinicalTrials.govTerms

COMPLETEDPhase 2< 1 mile

Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

NCT00051974

The purpose of this study is to evaluate how tumors in patients with non-small cell lung cancer respond to treatment with VELCADE alone versus VELCADE given with docetaxel and also to see what effects (good and bad) it has on you and your cancer.

Non-Small Cell Lung Cancer

Millennium Pharmaceuticals, Inc.155 participantsStarted Dec 2002

Birmingham, Alabama, United States • Los Angeles, California, United States • Los Angeles, California, United States +17 more locations

COMPLETEDPhase 2< 1 mile

Efficacy Study of EVT 201 in the Treatment of Elderly Patients With Daytime Sleepiness

NCT00401284

The purpose of this study is to determine whether a compound known as EVT 201 is effective in treating elderly patients diagnosed with primary insomnia who also have moderate daytime sleepiness.

Sleep Initiation and Maintenance Disorders

Evotec Neurosciences GmbH135 participantsStarted Nov 2006

Phoenix, Arizona, United States • Tucson, Arizona, United States • Los Angeles, California, United States +19 more locations

COMPLETEDPhase 4< 1 mile

Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age

NCT00192140

* To describe the proportion of individuals 5-49 years of age who shed vaccine strain viruses. * To describe the duration of shedding of vaccine viruses in individuals 5-49 years of age. * To describe the genotypic and phenotypic stability of shed vaccine viruses. * To describe the immune responses of FluMist in individuals 5-49 years of age. * To describe the safety of FluMist in individuals 5-49 years of age in relation to shedding and the immune response

MedImmune LLC345 participantsStarted Jun 2004

Miami, Florida, United States • Chicago, Illinois, United States • Bardstown, Kentucky, United States +8 more locations

COMPLETEDPhase 45.5 miles

Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis

NCT00121381

Atopic dermatitis, also called eczema, is characterized by redness, papulation (skin elevation) and pruritus (skin itching). The active ingredient of pimecrolimus inhibits the T-cell activation. These cells are involved in the inflammatory component of the disease. This study will test the safety of pimecrolimus Cream 1% with topical corticosteroid treatment (commonly used in eczema) in patients with severe atopic dermatitis.

Dermatitis, Atopic

Novartis400 participantsStarted May 2005

Huntington Beach, California, United States • San Diego, California, United States • Denver, Colorado, United States +10 more locations

COMPLETEDPhase 1/27.0 miles

Combination of Capecitabine and GTI-2040 in the Treatment of Renal Cell Carcinoma

NCT00056173

This phase II, 43 patient trial, will evaluate the efficacy of GTI-2040, an antisense oligonucleotide complementary to the R2 component of ribonucleotide reductase (RNR) mRNA, in combination with capecitabine, in the setting of advanced/metastatic renal cell carcinoma. Preclinical studies have shown synergy between GTI-2040 and capecitabine against renal cell carcinoma.

Carcinoma, Renal CellMetastases, Neoplasm

Aptose Biosciences Inc.43 participantsStarted Mar 2002

Concord, California, United States • Los Angeles, California, United States • Torrance, California, United States +7 more locations

COMPLETEDPhase 214 miles

A Phase 2 Study to Evaluate the Efficacy and Safety of 60mg of MM-093 in Patients With Active Rheumatoid Arthritis

NCT00458146

The purpose of this study is to determine whether MM-093 is safe and effective in the treatment of RA.

Rheumatoid Arthritis

Merrimack Pharmaceuticals100 participantsStarted Feb 2007

Montgomery, Alabama, United States • Gilbert, Arizona, United States • Scottsdale, Arizona, United States +17 more locations

COMPLETEDPhase 414 miles

Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Chemotherapy-Induced Neuropathy

NCT00380965

This study was designed to evaluate the safety and efficacy of Cesamet™ in controlling pain in subjects experiencing pain due to chemotherapy-induced neuropathic pain in patients with cancer.

Peripheral NeuropathyAntineoplastic Combined Chemotherapy Protocols

NEMA Research, Inc.23 participantsStarted Oct 2006

Aventura, Florida, United States • Naples, Florida, United States

COMPLETEDPhase 414 miles

Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder

NCT00127270

This study is designed to investigate the efficacy and safety of treatment of overactive bladder with darifenacin administered alone or in conjunction with behavioral modification therapies.

Urinary Incontinence

Novartis395 participantsStarted May 2005

Birmingham, Alabama, United States • Tucson, Arizona, United States • Culver City, California, United States +64 more locations

COMPLETEDPhase 417 miles

Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder

NCT00366002

This study will evaluate safety, efficacy and patient's perception of outcome after treatment with darifenacin (7.5 mg once daily (o.d.) with voluntary increase up to 15 mg o.d.) in patients with OAB who are dissatisfied with prior oxybutynin extended release (ER) or tolterodine extended release (ER) therapy.

Overactive Bladder (OAB)

Novartis500 participantsStarted Jun 2006

Birmingham, Alabama, United States • Chandler, Arizona, United States • Mesa, Arizona, United States +79 more locations

UNKNOWNPhase 325 miles

To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids

NCT00053560

The purpose of this clinical trial is to study the effects of GL701 on bone mineral density in women with active systemic lupus erythematosus (SLE) who are also receiving treatment with glucocorticoids (e.g., prednisone).

Genelabs Technologies155 participantsStarted Dec 2002

Tucson, Arizona, United States • Los Angeles, California, United States • North Hollywood, California, United States +23 more locations

COMPLETEDPhase 226 miles

Safety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer Patients

NCT00046371

The purpose of this study is to examine the immunological response rate to administration of the THERATOPE® vaccine in women with stable metastatic breast cancer who are being treated with aromatase inhibitors or Faslodex® and who do not require chemotherapy. Post-menopausal women on aromatase inhibitors or Faslodex® alone and pre-menopausal women on aromatase inhibitors plus luteinising hormone-releasing hormone (LH/RH)-agonist may be eligible to be enrolled. Patients must not have had radiotherapy or major surgery within four (4) weeks prior to entering the study. Information about the safety and tolerability of administration of the THERATOPE® vaccine will also be gathered during the course of the study.

Breast Neoplasms

Oncothyreon Canada Inc.Started Aug 2002

Berkeley, California, United States • San Francisco, California, United States • Santa Monica, California, United States +14 more locations

COMPLETEDPhase 326 miles

Study of Rebamipide Eye Drops to Treat Dry Eye

NCT00201981

The purpose of this study is to determine the potential safety and effectiveness of rebamipide eye drops, an investigational eye drop being developed for the treatment of keratoconjunctivitis sicca (dry eye).

Keratoconjunctivitis Sicca

Otsuka Pharmaceutical Development & Commercialization, Inc.740 participantsStarted May 2004

Birmingham, Alabama, United States • Glendale, Arizona, United States • Peoria, Arizona, United States +60 more locations

COMPLETEDPhase 431 miles

Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).

NCT00140036

This protocol describes procedures for the collection of blood samples for the intent of determining genetic contribution to the safety and efficacy of CPT/FU/LV.

Colorectal Neoplasms

Pfizer137 participantsStarted Sep 2002

Mobile, Alabama, United States • Tucson, Arizona, United States • Fresno, California, United States +31 more locations

COMPLETEDPhase 3205 miles

A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Clarithromycin Extended Release for the Treatment of Pneumonia in Adult Patients

NCT00643227

The study was performed to confirm that a single, 2.0 g oral dose of azithromycin sustained release (SR) at least as effective as 7 days of clarithromycin extended release (ER), 1.0 g by mouth once daily, when used to treat adults with mild to moderate community acquired pneumonia (CAP), and that both treatments were safe.

Pfizer504 participantsStarted Jan 2003

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Haleyville, Alabama, United States +69 more locations

COMPLETED205 miles

The Atrial High Rate Episodes in Pacemaker Patients

NCT00627328

Prospective study assessing the incidence of atrial high rate episodes (AHRE) in pacemaker patients with and without previously diagnosed AT.

ArrhythmiaAtrial FibrillationAtrioventricular Block+2 more

Medtronic Cardiac Rhythm and Heart Failure427 participantsStarted Jul 2000

Hot Springs, Arkansas, United States • Little Rock, Arkansas, United States • Fresno, California, United States +39 more locations

COMPLETEDPhase 3655 miles

Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™

NCT00600327

The primary objective of this study is to demonstrate the safety of the NexStent for treatment of carotid artery lesions undergoing stenting with adjunctive use of the FilterWire distal embolic protection device. The rates will be compared to an Objective Performance Criterion (OPC) derived from historic data from high-risk patients undergoing surgical intervention with Carotid endarterectomy. Patients included in this study are those at higher risk for complications associated with CEA.

Transient Ischemic AttackThromboembolic StrokeStroke Prevention

Boston Scientific Corporation488 participantsStarted Dec 2001

Phoenix, Arizona, United States • Mountain View, California, United States • Newport Beach, California, United States +16 more locations

COMPLETEDPhase 4967 miles

Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients

NCT00051012

The purpose of this study is to provide an opportunity for patients who exhibit progressive disease while receiving placebo on the companion 93-04-11 study to receive ONTAK. It is also designed to determine the effectiveness of ONTAK in Cutaneous T-cell Lymphoma (CTCL) patients whose tumors do not express CD25.

Lymphoma, T-Cell, CutaneousMycosis FungoidesSezary Syndrome

Eisai Inc.86 participantsStarted Sep 1995

Houston, Texas, United States • Saint Leonard's, New South Wales, Australia • Westmead, New South Wales, Australia +31 more locations

TERMINATEDPhase 31114 miles

GALLANT 4 Tesaglitazar vs. Glibenclamide

NCT00255541

This is a 52-week randomized, double-blind, parallel-group, multi-center, active-controlled (glibenclamide) study of tesaglitazar in patients with type 2 diabetes, not adequately controlled on diet and lifestyle advice alone during the run-in period. The study comprises a 6 week placebo single blind run in period followed by a 52-week double blind treatment period and a 3-week follow-up period. Tesaglitazar and glibenclamide will be titrated to optimal effect or highest tolerable dose during the first 12 weeks.

Type 2 Diabetes

AstraZeneca580 participantsStarted Sep 2004

Antwerp, Belgium • Braine-l'Alleud, Belgium • Hasselt, Belgium +63 more locations

PreviousPage 428 of 436Next

Heart Diseasein Miami